{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Atlanta&page=13&state=Georgia", "query": { "state": "Georgia", "city": "Atlanta", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 13063, "total_pages": 1307, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Atlanta&page=14&state=Georgia&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Atlanta&page=12&state=Georgia&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T05:57:49.129Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00722553", "title": "Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carcinoma, Transitional Cell", "Bladder Cancer", "Bladder Neoplasm" ], "interventions": [ { "name": "Pralatrexate Injection", "type": "DRUG" }, { "name": "Vitamin B12", "type": "DIETARY_SUPPLEMENT" }, { "name": "Folic Acid", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Acrotech Biopharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2008-07", "completion_date": "2011-09", "has_results": true, "last_update_posted_date": "2019-12-17", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 4, "location_summary": "Tucson, Arizona • Atlanta, Georgia • Rochester, New York + 1 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Rochester", "state": "New York" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00722553" }, { "nct_id": "NCT00896337", "title": "EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Iliac Artery Stenosis" ], "interventions": [ { "name": "Epic™ Nitinol Stent System", "type": "DEVICE" }, { "name": "Anti-platelet therapy", "type": "DRUG" }, { "name": "Anti-coagulation therapy", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2009-05", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2015-05-07", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 28, "location_summary": "Tucson, Arizona • Brandon, Florida • Fort Lauderdale, Florida + 24 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Brandon", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00896337" }, { "nct_id": "NCT01179477", "title": "QuickFlex Micro Left Ventricular Lead Post Approval Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Implantation of a QuickFlex® μ Model 1258T LV Lead", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1930, "start_date": "2010-09", "completion_date": "2017-09", "has_results": true, "last_update_posted_date": "2019-08-12", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 77, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Anchorage, Alaska + 67 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01179477" }, { "nct_id": "NCT06725277", "title": "The OBSERVE Protocol", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Major Depression Disorder" ], "interventions": [ { "name": "Spravato", "type": "DRUG" }, { "name": "IV Ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 450, "start_date": "2024-01-21", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 8, "location_summary": "Milford, Connecticut • New Haven, Connecticut • Atlanta, Georgia + 5 more", "locations": [ { "city": "Milford", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Moore", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT06725277" }, { "nct_id": "NCT03603275", "title": "Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hemophilia A" ], "interventions": [ { "name": "New FVIII products", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 3, "start_date": "2018-08-06", "completion_date": "2020-05-14", "has_results": false, "last_update_posted_date": "2022-08-25", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 27, "location_summary": "La Jolla, California • Aurora, Colorado • New Haven, Connecticut + 23 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03603275" }, { "nct_id": "NCT00097357", "title": "BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Venous Thrombosis", "Pulmonary Embolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Enoxaparin Placebo", "type": "DRUG" }, { "name": "Apixaban Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 1238, "start_date": "2004-10", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2010-03-02", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Northport, Alabama + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097357" }, { "nct_id": "NCT04678557", "title": "A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "VC-01 Combination Product", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "ViaCyte", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 31, "start_date": "2019-06-25", "completion_date": "2021-11-19", "has_results": true, "last_update_posted_date": "2023-10-18", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 4, "location_summary": "Escondido, California • Walnut Creek, California • Atlanta, Georgia + 1 more", "locations": [ { "city": "Escondido", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04678557" }, { "nct_id": "NCT00146328", "title": "Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Tipranavir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 997, "start_date": "2001-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-03-06", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 86, "location_summary": "Phoenix, Arizona • Berkeley, California • Fountain Valley, California + 56 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Berkeley", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00146328" }, { "nct_id": "NCT04669665", "title": "A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depressive Disorder, Major", "Suicidal" ], "interventions": [ { "name": "SLS-002", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of care", "type": "OTHER" }, { "name": "Intranasal device", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DEVICE" ], "sponsor": "Seelos Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 164, "start_date": "2020-12-17", "completion_date": "2023-07-14", "has_results": false, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 21, "location_summary": "Orange, California • Panorama City, California • San Diego, California + 18 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Panorama City", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04669665" }, { "nct_id": "NCT01610765", "title": "A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Herpes Simplex Virus" ], "interventions": [ { "name": "Novel Antiviral Drug", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "98 Days", "sex": "ALL", "summary": "1 Day to 98 Days" }, "enrollment_count": 0, "start_date": "2016-01", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2016-06-07", "last_synced_at": "2026-11-04T05:57:49.129Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Aurora, Colorado + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01610765" } ] }